Response Evaluation of Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma with Respect to Tumour Size, Number of Lesion, and Alpha-Fetoprotein (AFP) Level
Background: Transarterial chemoembolization (TACE) is widely used as a palliative treatment for unresectable hepatocellular carcinoma (HCC). TACE is also used as bridging therapy before liver transplantation to avoid tumour progression and considered for downstaging to fulfill tumour resection or li...
Autores principales: | Adaninggar PN, Ulfa Kholili, Ummi Maimunah, Poernomo B Setiawan, Iswan A Nusi, Herrry Purbayu, Titong Sugihartono, Budi Widodo, Husin Thamrin, Amie Vidyani |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
Interna Publishing
2016-05-01
|
Colección: | The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy |
Materias: | |
Acceso en línea: | http://ina-jghe.com/journal/index.php/jghe/article/view/516/439 |
Ejemplares similares
-
Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation
por: Gauri Mishra, et al.
Publicado: (2020-05-01) -
Lower Number and Percentage of Activated Natural Killer Cells in Colorectal Cancer Patients
por: Amie Vidyani, et al.
Publicado: (2022-12-01) -
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆
por: Dongdong Xia, et al.
Publicado: (2025-01-01) -
Alpha-Fetoprotein (AFP): Solved and Unsolved Problems
por: Garry Abelev, et al.
Publicado: (2020-12-01) -
Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients
por: Deasy Natalia Adriana, et al.
Publicado: (2022-08-01)